Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.

The American journal of pathology - 1 May 1996

Krajewska M, Krajewski S, Epstein J I, Shabaik A, Sauvageot J, Song K, Kitada S, Reed J C

Abstract excerpt

Proteins encoded by bcl-2 family genes are important regulators of programmed cell death and apoptosis. Alterations in the expression of these apoptosis-regulating genes can contribute to the origins of cancer, as well as adversely influence tumor responses to chemo- and radiotherapy. Using antib...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Apoptosis
Share to Immunohistochemistry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Proteins

Share to Phenotype

Share to Prostatic Neoplasms

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins c-bcl-2

Source

Open in PubMed Open full text

Identifiers

PMID: 8623925
PMCID: PMC1861561

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-8623925-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.PMID 8623925Read ↗

Correlation of p53 protein accumulation and Bcl-2 overexpression with histopathological features in prostatic cancer.Semantic proximity Read ↗

Apoptosis in prostate cancer: progressive and therapeutic implications (Review).Semantic proximity Read ↗

BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticitySemantic proximity Read ↗

Bcl-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated with Taxane-Based ChemotherapySemantic proximity Read ↗

Prognostic significance of Bcl-2 in clinically localized prostate cancer.Semantic proximity Read ↗

Chemosensitization of Prostate Cancer by Modulating Bcl-2 Family ProteinsSemantic proximity Read ↗

Differential gene expression of BCL‐2, ZEB2‑AS1 and BALR‐2 in prostate cancer and benign prostatic hyperplasiaSemantic proximity Read ↗

Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak.Semantic proximity Read ↗

Truncated Bcl-2, a potential pre-metastatic marker in prostate cancer.Semantic proximity Read ↗

TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.Semantic proximity Read ↗

Prognostic relevance of Bcl‐2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the geneSemantic proximity Read ↗

Relation between Bcl-2, cell proliferation, and the androgen receptor status in prostate tissue and precursors of prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.